Viewing Study NCT00143234


Ignite Creation Date: 2025-12-25 @ 2:20 AM
Ignite Modification Date: 2026-02-06 @ 12:44 AM
Study NCT ID: NCT00143234
Status: COMPLETED
Last Update Posted: 2021-01-27
First Post: 2005-08-31
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hypertension View
None Hyperlipidemia View
Keywords: